Emergent BioSolutions (NYSE:EBS) Given New $12.00 Price Target at Benchmark
Emergent BioSolutions (NYSE:EBS – Free Report) had its price target hoisted by Benchmark from $8.00 to $12.00 in a research note issued to investors on Thursday,Benzinga reports. The brokerage currently has a buy rating on the biopharmaceutical company’s stock. Separately, Rodman & Renshaw reissued a “buy” rating and issued a $16.00 target price on shares […]
8 Nov 22:37 · The Markets Daily